XML 38 R27.htm IDEA: XBRL DOCUMENT
v3.19.1

Goodwill and Intangible Assets (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract] |
Summary of intangible assets by major asset class | The following sets forth the goodwill and intangible assets by major asset class:
|  |  | March 31, 2019 |  | December 31, 2018
| Useful Life (Yrs) | Gross |  | Accumulated Amortization |  | Net Book Value |  | Gross |  | Accumulated Amortization |  | Net Book Value
Indefinite lived: |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill(a) |  |  | $ | 10,513,371 |  |  | $ | — |  |  | $ | 10,513,371 |  |  | $ | 10,513,371 |  |  | $ | — |  |  | $ | 10,513,371 |
Definite lived: |  |  |  |  |  |  |  |  |  |  |  |  |
Patents | 8 – 17 |  | 5,802,528 |  |  | (5,757,181 | ) |  | 45,347 |  |  | 5,802,528 |  |  | (5,742,079 | ) |  | 60,449 |
Licenses | 8 – 17 |  | 1,323,761 |  |  | (1,226,544 | ) |  | 97,217 |  |  | 1,323,761 |  |  | (1,219,357 | ) |  | 104,404 |
CELLECTRA®(b) | 5 – 11 |  | 8,106,270 |  |  | (7,785,959 | ) |  | 320,311 |  |  | 8,106,270 |  |  | (7,679,190 | ) |  | 427,080 |
GHRH(b) | 11 |  | 335,314 |  |  | (311,551 | ) |  | 23,763 |  |  | 335,314 |  |  | (303,630 | ) |  | 31,684 |
Bioject(c) | 2 – 15 |  | 5,100,000 |  |  | (1,955,556 | ) |  | 3,144,444 |  |  | 5,100,000 |  |  | (1,882,222 | ) |  | 3,217,778 |
Other(d) | 18 |  | 4,050,000 |  |  | (3,187,500 | ) |  | 862,500 |  |  | 4,050,000 |  |  | (3,131,250 | ) |  | 918,750 |
Total intangible assets |  |  | 24,717,873 |  |  | (20,224,291 | ) |  | 4,493,582 |  |  | 24,717,873 |  |  | (19,957,728 | ) |  | 4,760,145 |
Total goodwill and intangible assets |  |  | $ | 35,231,244 |  |  | $ | (20,224,291 | ) |  | $ | 15,006,953 |  |  | $ | 35,231,244 |  |  | $ | (19,957,728 | ) |  | $ | 15,273,516 |
(a) | Goodwill was recorded from the Inovio AS acquisition in January 2005, the acquisition of VGX in June 2009 and the acquisition of Bioject in April 2016 for $3.9 million, $6.2 million and $400,000, respectively.
(b) | CELLECTRA® and GHRH are developed technologies which were recorded from the acquisition of VGX.
(c) | Bioject intangible assets represent the estimated fair value of developed technology and intellectual property which were recorded from the Bioject asset acquisition.
(d) | Other intangible assets represent the estimated fair value of acquired intellectual property from the Inovio AS acquisition.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267 + Details
Name: | us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration